CDC Releases STD Surveillance Report
by: ASRM Office of Public Affairs
Published in ASRM BUlletin Volume 16, No. 2
The Centers for Disease Control and Prevention (CDC) released its 2012 sexually transmitted disease (STD) surveillance data. This annual report of statistics and trends for three reportable sexually transmitted diseases in the United States (chlamydia, gonorrhea and syphilis) shows that STD rates for all three diseases continue to increase. The CDC is calling a spike in the number of cases of primary and secondary syphilis troubling. Reportable syphilis cases increased 11% in 2012 with men, particularly gay and bisexual men, accounting for the spike entirely. The full 2012 STD surveillance data can be found on the CDC website at: www.cdc.gov/std/stats12/.
CDC’s guidelines for STD screening and treatment are available at: http://www.cdc.gov/std/treatment/2010/.
The guidelines call for:
- Annual chlamydia screening for all sexually active women age 25 and under, as well as older women with risk factors such as new or multiple sex partners.
- Yearly gonorrhea screening for at-risk sexually active women (e.g., those with new or multiple sex partners, and women who live in communities with a high burden of disease).
- Syphilis, HIV, chlamydia, and hepatitis B screening for all pregnant women, and gonorrhea screening for at-risk pregnant women starting early in pregnancy, with repeat testing as needed, to protect the health of mothers and their infants.
- Screening at least once a year for syphilis, chlamydia, gonorrhea, and HIV for all sexually active gay, bisexual, and other men who have sex with men (MSM). MSM who have multiple or anonymous partners should be screened more frequently for STDs (i.e., at 3-to-6 month intervals). In addition, MSM who have sex in conjunction with illicit drug use (particularly methamphetamine use) or whose sex partners participate in these activities should be screened more frequently.
The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at email@example.com.